FDA
-
-
-
-
-
-
-
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
-
-
-
-
-
-
-
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
-
-
-
-
-
-
-
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
-
-
-
-
-
-
-
Agilent Announces Enhanced xCELLigence RTCA Software Pro to Support Regulatory Compliance Requirements
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/25: Retailers Express, Nordstrom Gain Following Earnings; Verrica Pharma Sinks on FDA CRL (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 05/26: (NBRV) (PIRS) (GME) Higher; (LRMR) (LOTZ) (TVTX) Lower (more...)
-
-
-
-
-
-
-
Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
-
322,995 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

